Raúl Ferrando‐Piqueres

ORCID: 0000-0002-5198-9969
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Antimicrobial Resistance in Staphylococcus
  • Microscopic Colitis
  • COVID-19 Clinical Research Studies
  • Inflammatory Bowel Disease
  • Surgical site infection prevention
  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Hematological disorders and diagnostics
  • Bone health and treatments
  • Prostate Cancer Treatment and Research
  • Pregnancy and Medication Impact
  • Respiratory viral infections research
  • Antibiotic Resistance in Bacteria
  • Celiac Disease Research and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Inflammatory mediators and NSAID effects
  • Pharmaceutical Practices and Patient Outcomes
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Helicobacter pylori-related gastroenterology studies
  • Antibiotic Use and Resistance

Hospital General Universitari de Castelló
2017-2025

This study examines the implementation of a collaborative telepharmacy programme in an outpatient pharmaceutical care unit (OPCU) at tertiary hospital. The coordinates between hospital pharmacy, community pharmacies, distributor, and regional official college pharmacists to optimise medication dispensing delivery outpatients. addressed challenges operations, logistics, technology, legality, training information. A protocol was developed defining circuit, including criteria for patient...

10.1136/ejhpharm-2025-004524 article EN European Journal of Hospital Pharmacy 2025-05-19

The aims of this study are (i) to develop a population pharmacokinetic/pharmacodynamic model daptomycin in patients with normal and impaired renal function, (ii) establish the optimal dose recommendation clinical practice. Several structural PK models including linear non-linear binding kinetics were evaluated. Monte Carlo simulations conducted fixed combination creatinine clearance (30–90 mL/min/1.73 m2) body weight (50–100 kg). final dataset included 46 157 observations. A two-compartment...

10.3390/pharmaceutics14102226 article EN cc-by Pharmaceutics 2022-10-18

The study aimed to assess acceptability and patient experience of Certolizumab (CZP) self-injection with AVA® clarify device preference after switching CZP from the syringe or auto-injection pen in rheumatoid arthritis (RA), psoriatic (PsA) axial spondyloarthritis (axSpA) patients.A multicentre open-label, cross-sectional prospective among four Spanish hospitals was performed. Adult RA, PsA, axSpA patients treated for at least 6 months were recruited. At first visit, completed Pre-AVA®...

10.1111/jcpt.13820 article EN Journal of Clinical Pharmacy and Therapeutics 2022-12-01

We investigated physical and chemical stability of daptomycin vancomycin in heparin or sodium citrate lock solutions. The aim this study was to find the optimal combination antimicrobials additives for solutions, which maximized patient safety.Vancomycin were diluted with achieve final concentrations vancomycin-heparin 2.5 mg/mL-833.33 U/mL, vancomycin-citrate 2.5-33.3 mg/mL, daptomycin-heparin 5 mg/mL-800 daptomycin-citrate 5-32 mg/mL they stored at room temperature (+25°C), 4°C, -20°C,...

10.1177/11297298211045893 article EN The Journal of Vascular Access 2021-09-24

<h3>Background</h3> Since April 2014, an antimicrobial stewardship programme (ASP) has been implemented in hospitalisation units a 580 bed hospital. The ASP team comprises two clinical pharmacists, infectious diseases physicians and microbiologists who, through weekly meetings, carry out their activities. reasons for intervention are: not justified associations, dosing, pharmacokinetic monitoring, duration of antibiotic use more than 8 days inappropriate prescription as indication and/or...

10.1136/ejhpharm-2017-000640.80 article EN Clinical pharmacy 2017-02-25

<h3>Background and importance</h3> Cytochrome P enzymes play a key role in drug metabolism it is essential to understanding some interactions. <h3>Aim objectives</h3> Optimising pharmacotherapy prostate cancer patients through the identification of interactions between anti-androgenic therapy patient's usual medication. <h3>Material methods</h3> Patients on abiraterone, enzalutamide or apalutamide treatment were identified pharmacy computerised record dispensations. Their medication was...

10.1136/ejhpharm-2022-eahp.129 article EN Section 4: Clinical pharmacy services 2022-03-01
Coming Soon ...